Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 9, 2009, Pages 1504-1509

  Kim, Jeong Hwan ^a   Sinn, Dong Hyun ^b   Son, Hee Jung ^b   Kim, Jae J ^b   Rhee, Jong Chul ^b   Rhee, Poong Lyul ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Gastroesophageal reflux disease; Non cardiac chest pain; Rabeprazole trial

Indexed keywords

RABEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG MEGADOSE; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; NONCARDIAC CHEST PAIN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; CHEST PAIN; DRUG ADMINISTRATION SCHEDULE; EMPIRICAL RESEARCH; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTON PUMP INHIBITORS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 69949165048     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05859.x     Document Type: Article

References (25)

1. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting - a population-based study. Aliment. Pharmacol. Ther. 2003 17 : 1115 1124.
2. Locke GR 3rd., Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 : 1448 1456.
3. Chambers J, Bass C. Chest pain with normal coronary anatomy: a review of natural history and possible etiologic factors. Prog. Cardiovasc. Dis. 1990 33 : 161 184.
4. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Aliment. Pharmacol. Ther. 2004 20 : 909 915.
5. Kim JH, Rhee PL, Park EH, Son HJ, Kim JJ, Rhee JC. Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea. J. Gastroenterol. Hepatol. 2007 22 : 320 325.
6. Faybush EM, Fass R. Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol. Clin. North Am. 2004 33 : 41 54.
7. Pandak WM, Arezo S, Everett S et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J. Clin. Gastroenterol. 2002 35 : 307 314.
8. Wong WM, Lai KC, Lau CP et al. Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain. Aliment. Pharmacol. Ther. 2002 16 : 465 471.
9. Richter JE. Chest pain and gastroesophageal reflux disease. J. Clin. Gastroenterol 2000 30 : S39 41.
10. Fass R, Fennerty MB, Ofman JJ et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998 115 : 42 9.
11. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am. J. Gastroenterol. 2005 100 : 1226 1232.
12. Wang WH, Huang JQ, Zheng GF et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? A meta-analysis. Arch. Intern. Med. 2005 165 : 1222 1228.
13. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann. Intern. Med. 2004 140 : 518 527.
14. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999 45 : 172 180.
15. Jamieson JR, Stein HJ, DeMeester TR et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am. J. Gastroenterol. 1992 87 : 1102 1111.
16. Katz PO. Diagnosis and therapy of noncardiac chest pain: a clinical dilemma. J. Clin. Gastroenterol. 2002 35 : 292 294.
17. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999 44 (Suppl. 2 S1 16.
18. Wong WM. Use of proton pump inhibitor as a diagnostic test in NCCP. J. Gastroenterol. Hepatol. 2005 20 (Suppl S14 17.
19. Bruley des Varannes S. The proton-pump inhibitor test: pros and cons. Eur. J. Gastroenterol. Hepatol. 2004 16 : 847 852.
20. Bruley des Varannes S, Levy P, Lartigue S, Dellatolas F, Lemaire M, Galmiche JP. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment. Pharmacol. Ther. 1994 8 : 309 314.
21. Bautista J, Fullerton H, Briseno M, Cui H, Fass R. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial. Aliment. Pharmacol. Ther. 2004 19 : 1123 1130.
22. Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin. Gastroenterol. Hepatol. 2003 1 : 333 344.
23. Dickman R, Emmons S, Cui H et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment. Pharmacol. Ther. 2005 22 : 547 555.
24. Wong WM, Lai KC, Lam KF et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment. Pharmacol. Ther. 2003 18 : 595 604.
25. Wong WM, Lam KF, Cheng C et al. Population based study of noncardiac chest pain in southern Chinese: Prevalence, psychosocial factors and health care Utilization. World J. Gastroenterol. 2004 10 : 707 712.